Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02273752 | Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer | terminated | Phase 2 | 2 | Emory UniversityOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00096109 | Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2017 | clinicaltrials |
| NCT00045591 | Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer | terminated | Phase 2 | 39 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT02213744 | MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients(HERMIONE) | terminated | Phase 2 / Phase 3 | 113 | Merrimack PharmaceuticalsINDUSTRY | 9 | Jan 6, 2017 | clinicaltrials |
| NCT01708798 | Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer | terminated | Phase 2 / Phase 3 | 44 | University of British ColumbiaOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT01167192 | Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer | terminated | Phase 2 | 10 | Washington University School of MedicineOTHER | 1 | Dec 30, 2016 | clinicaltrials |
| NCT00752986 | ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial(ZACFAST) | terminated | Phase 2 | 39 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT00977379 | A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis(XERAD) | terminated | Phase 2 | 24 | Hoffmann-La RocheINDUSTRY | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02645175 | Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue | terminated | Phase 2 | 3 | Meriyana Bio Inc.INDUSTRY | 0 | Oct 21, 2016 | clinicaltrials |
| NCT01194869 | Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer | terminated | Phase 2 | 25 | Emory UniversityOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT01910844 | Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes(META2) | terminated | Phase 2 | 3 | Centre Jean PerrinOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT01498588 | Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer | terminated | Phase 2 | 7 | Emory UniversityOTHER | 1 | Oct 3, 2016 | clinicaltrials |
| NCT00603408 | Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer | terminated | Phase 2 | 5 | Washington University School of MedicineOTHER | 1 | Aug 19, 2016 | clinicaltrials |
| NCT01132664 | Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer | terminated | Phase 1 / Phase 2 | 72 | Novartis PharmaceuticalsINDUSTRY | 6 | Aug 17, 2016 | clinicaltrials |
| NCT00427427 | Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer | terminated | Phase 2 | 75 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 1, 2016 | clinicaltrials |
| NCT01528345 | Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer | terminated | Phase 2 | 97 | Novartis PharmaceuticalsINDUSTRY | 15 | Jul 11, 2016 | clinicaltrials |
| NCT01339000 | Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy | terminated | Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Jun 22, 2016 | clinicaltrials |
| NCT00567879 | A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab | terminated | Phase 1 / Phase 2 | 56 | Novartis PharmaceuticalsINDUSTRY | 6 | May 9, 2016 | clinicaltrials |
| NCT01069796 | Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 64 | ARCAGY/ GINECO GROUPOTHER | 1 | Mar 17, 2016 | clinicaltrials |
| NCT01662726 | A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth(IPET) | terminated | Phase 2 | 13 | Imperial College LondonOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT00546364 | Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer(IXTEND) | terminated | Phase 2 | 62 | R-PharmINDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00773474 | Lonafarnib in Metastatic Breast Cancer | terminated | Phase 2 | 29 | George SledgeOTHER | 1 | Feb 18, 2016 | clinicaltrials |
| NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | terminated | Phase 2 | 7 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01029925 | Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL) | terminated | Phase 2 | 7 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 12, 2016 | clinicaltrials |
| NCT01534455 | Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA) | terminated | Phase 2 | 43 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT00824733 | Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 6 | Bhuvaneswari RamaswamyOTHER | 1 | Jan 14, 2016 | clinicaltrials |
| NCT01919229 | A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)(MONALEESA-1) | terminated | Phase 2 | 14 | Novartis PharmaceuticalsINDUSTRY | 3 | Jan 1, 2016 | clinicaltrials |
| NCT00347438 | Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer | terminated | Phase 2 | 18 | University of ChicagoOTHER | 2 | Dec 14, 2015 | clinicaltrials |
| NCT00636441 | Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer | terminated | Phase 2 | 56 | Duke UniversityOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT00216047 | PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 7 | Hoosier Cancer Research NetworkOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT00777335 | Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer | terminated | Phase 2 | 4 | Translational Research in OncologyOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT00148720 | Capecitabine in Women With Operable Breast Cancer | terminated | Phase 2 | 80 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT00780000 | Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer | terminated | Phase 2 | 4 | Bristol-Myers SquibbINDUSTRY | 0 | Nov 4, 2015 | clinicaltrials |
| NCT01056757 | Treatment With Ribavirin for Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 4 | Jewish General HospitalOTHER | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00372996 | Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer | terminated | Phase 2 | 219 | PfizerINDUSTRY | 9 | Oct 28, 2015 | clinicaltrials |
| NCT01809171 | Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients | terminated | Phase 2 / Phase 3 | 15 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Oct 21, 2015 | clinicaltrials |
| NCT02042885 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer | terminated | Phase 1 / Phase 2 | 79 | Otsuka Novel Products GmbHINDUSTRY | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00356681 | A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer | terminated | Phase 2 | 282 | AmgenINDUSTRY | 0 | Oct 15, 2015 | clinicaltrials |
| NCT00437073 | Brain Metastases In ErbB2-Positive Breast Cancer | terminated | Phase 2 | 22 | GlaxoSmithKlineINDUSTRY | 11 | Oct 15, 2015 | clinicaltrials |
| NCT01985841 | Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer | terminated | Phase 2 | 34 | Hellenic Oncology Research GroupOTHER | 1 | Oct 8, 2015 | clinicaltrials |
| NCT01047774 | The Effect of Soy Protein on Post- Breast Cancer Surgery Pain | terminated | Phase 2 | 6 | Dr. Yoram ShirOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01120171 | Myocet Plus Endoxan for Older Patients With Breast Cancer | terminated | Phase 2 | 64 | Hellenic Oncology Research GroupOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT00754702 | Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer | terminated | Phase 2 | 16 | University Hospital of CreteOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT00377780 | Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer(MYOHERTAX) | terminated | Phase 2 | 60 | Laurence J.C. van WarmerdamOTHER | 1 | Sep 23, 2015 | clinicaltrials |
| NCT01161368 | A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients | terminated | Phase 2 | 9 | Central European Cooperative Oncology GroupOTHER | 2 | Aug 13, 2015 | clinicaltrials |
| NCT01067989 | Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer | terminated | Phase 2 | 22 | HaEmek Medical Center, IsraelOTHER | 1 | Jul 8, 2015 | clinicaltrials |
| NCT01375023 | Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer | terminated | Phase 2 | 3 | European Institute of OncologyOTHER | 1 | Jun 22, 2015 | clinicaltrials |
| NCT00694200 | Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer | terminated | Phase 2 | 13 | Hellenic Oncology Research GroupOTHER | 1 | May 29, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Feb 3, 2017source: clinicaltrials